Cargando…
Genetic variation in the farnesoid X-receptor predicts Crohn’s disease severity in female patients
The farnesoid X receptor (FXR) is implicated in Crohn's disease (CD) pathogenesis. It is unclear how genetic variation in FXR impacts CD severity versus genetic variation in nuclear receptors such as pregnane X receptor (PXR) and the multi-drug resistance protein 1 (MDR1, ABCB1). To evaluate FX...
Autores principales: | Wilson, Aze, Wang, Qian, Almousa, Ahmed A., Jansen, Laura E., Choi, Yun-hee, Schwarz, Ute I., Kim, Richard B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366697/ https://www.ncbi.nlm.nih.gov/pubmed/32678214 http://dx.doi.org/10.1038/s41598-020-68686-9 |
Ejemplares similares
-
A174 A NOVEL MECHANISM OF CROHN’S DISEASE SEVERITY IN WOMEN: EVALUATING THE IMPACT OF AN ESTROGEN-FARNESOID X RECEPTOR INTERACTION ON INTESTINAL BARRIER FUNCTION
por: Taylor, D, et al.
Publicado: (2023) -
Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease
por: Wilson, Aze, et al.
Publicado: (2020) -
Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011) -
Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis
por: van Schaik, Fiona D. M., et al.
Publicado: (2012) -
The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)